Pfizer Appoints Parmjot Bains as Gulf Cluster Country Manager
Dubai, United Arab Emirates, 14 September 2022: Pfizer announced today the appointment of Dr. Parmjot Bains as Gulf Cluster Country Manager within its Emerging Markets business unit. Dr. Bains’ experience spans more than 18 years in various fields with 7 years heading several global roles at Pfizer. Previously, Dr. Bains was the Regional Commercial Lead APAC for Pfizer’s Hospital Business, where she worked cross-culturally with Pfizer’s global teams across the US and Asia Pacific Region to deliver ground-breaking, innovative access solutions and products that transform patient outcomes.
In her new role, Dr. Bains will oversee the Pfizer business in the United Arab Emirates, Bahrain, Kuwait, Oman, Qatar and Yemen.
Commenting on her appointment, Dr. Bains said: ” It is an exciting time to be here and pursue our journey in the Gulf where Pfizer has been operating and serving patients’ needs for over 40 years”.
She added: “I look forward to extending Pfizer’s momentum, leading several ongoing projects and forging even closer partnerships and alliances with healthcare professionals, our distributors, communities, and governments that will change and impact the lives of millions of people across the Gulf countries. We have a truly fantastic team in each of the markets, and together, we will continue to deliver breakthroughs that address critical health challenges and unmet patients’ needs, and to drive new awareness programs across our strategic therapeutic areas.”
An experienced global healthcare executive trained in clinical medicine, and experienced in strategy with McKinsey and Company, drug development as a Biotech CEO, and global commercial roles within Pfizer, Dr. Bains has received the US-based Healthcare Business Association Rising Star Award in 2022 recognizing leadership in the healthcare industry and is a graduate of the Australian Institute of Company Directors.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at http://www.Pfizer.com.